Cover Image
Market Research Report

Cardiovascular Prosthetic Devices - Medical Devices Pipeline Assessment, 2018

Published by GlobalData Product code 350920
Published Content info 270 Pages
Immediate Delivery Available
Price
Back to Top
Cardiovascular Prosthetic Devices - Medical Devices Pipeline Assessment, 2018
Published: June 14, 2018 Content info: 270 Pages
Description

GlobalData's Medical Devices sector report, "Cardiovascular Prosthetic Devices - Medical Devices Pipeline Assessment, 2018" provides an overview of Cardiovascular Prosthetic Devices currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Cardiovascular Prosthetic Devices pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Cardiovascular Prosthetic Devices under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Cardiovascular Prosthetic Devices and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Cardiovascular Prosthetic Devices under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date
Table of Contents
Product Code: GDME0591EPD

Table of Contents

1 Table of Contents

1 Table of Contents 2

  • 1.1 List of Tables 7
  • 1.2 List of Figures 14

2 Introduction 15

  • 2.1 Cardiovascular Prosthetic Devices Overview 15

3 Products under Development 16

  • 3.1 Cardiovascular Prosthetic Devices - Pipeline Products by Stage of Development 16
  • 3.2 Cardiovascular Prosthetic Devices - Pipeline Products by Segment 17
  • 3.3 Cardiovascular Prosthetic Devices - Pipeline Products by Territory 18
  • 3.4 Cardiovascular Prosthetic Devices - Pipeline Products by Regulatory Path 19
  • 3.5 Cardiovascular Prosthetic Devices - Pipeline Products by Estimated Approval Date 20
  • 3.6 Cardiovascular Prosthetic Devices - Ongoing Clinical Trials 21

4 Cardiovascular Prosthetic Devices - Pipeline Products under Development by Companies 22

  • 4.1 Cardiovascular Prosthetic Devices Companies - Pipeline Products by Stage of Development 22
  • 4.2 Cardiovascular Prosthetic Devices - Pipeline Products by Stage of Development 25

5 Cardiovascular Prosthetic Devices Companies and Product Overview 28

  • 5.1 4Tech Cardio Ireland Ltd Company Overview 28
  • 5.2 Abbott Vascular Inc Company Overview 31
  • 5.3 Admedus Ltd Company Overview 34
  • 5.4 Ample Medical Inc Company Overview 35
  • 5.5 Ancora Heart Inc Company Overview 36
  • 5.6 Aporo Biomedical, Inc. (Inactive) Company Overview 39
  • 5.7 BioStable Science & Engineering, Inc. Company Overview 40
  • 5.8 BioVentrix Inc Company Overview 41
  • 5.9 CARAG AG Company Overview 44
  • 5.10 Cardiac Dimensions Inc Company Overview 47
  • 5.11 Cardiosolutions Inc Company Overview 50
  • 5.12 Celyad SA Company Overview 51
  • 5.13 Children's Hospital Boston Company Overview 54
  • 5.14 Cierra, Inc. (Inactive) Company Overview 56
  • 5.15 CollPlant Ltd Company Overview 57
  • 5.16 coramaze technologies GmbH Company Overview 58
  • 5.17 CoreMedic AG Company Overview 59
  • 5.18 Coroneo Inc. Company Overview 62
  • 5.19 CUBE SRL Company Overview 63
  • 5.20 Daidalos Solutions BV Company Overview 64
  • 5.21 Dextera Surgical Inc Company Overview 66
  • 5.22 Edwards Lifesciences Corp Company Overview 67
  • 5.23 Emory University Company Overview 74
  • 5.24 Ension, Inc. Company Overview 76
  • 5.25 Georgia Institute of Technology Company Overview 77
  • 5.26 Hangzhou DeJin Medtech Co Ltd Company Overview 78
  • 5.27 Kardium Inc Company Overview 80
  • 5.28 Kephalios SAS Company Overview 81
  • 5.29 Lartim Medical Ltd Company Overview 82
  • 5.30 Lifetech Scientific (Shenzhen) Co Ltd Company Overview 83
  • 5.31 LivaNova PLC Company Overview 89
  • 5.32 Mardil Medical, Inc. Company Overview 91
  • 5.33 Mayo Clinic Company Overview 94
  • 5.34 Medtentia International Ltd Oy Company Overview 95
  • 5.35 MiCardia Corp Company Overview 97
  • 5.36 Michigan Critical Care Consultants, Inc. Company Overview 98
  • 5.37 Micro Interventional Devices, Inc. Company Overview 100
  • 5.38 Millipede LLC Company Overview 105
  • 5.39 Mitral Heal Company Overview 108
  • 5.40 Mitralign Inc Company Overview 109
  • 5.41 Mitralix Ltd. Company Overview 112
  • 5.42 Mitre Medical Corp Company Overview 113
  • 5.43 MVRx, Inc. Company Overview 115
  • 5.44 Neochord Inc Company Overview 118
  • 5.45 North Carolina State University Company Overview 122
  • 5.46 Occlutech International AB Company Overview 123
  • 5.47 Phoenix Cardiac Devices, Inc. Company Overview 125
  • 5.48 Rambam Health Care Campus Company Overview 128
  • 5.49 ReCor Medical Inc Company Overview 129
  • 5.50 SCR, Inc. Company Overview 130
  • 5.51 SeptRx, Inc. (Inactive) Company Overview 131
  • 5.52 St. Jude Medical LLC Company Overview 132
  • 5.53 Strait Access Technologies (Pty) Ltd Company Overview 138
  • 5.54 Sutura, Inc. (Inactive) Company Overview 139
  • 5.55 Swissimplant AG (Inactive) Company Overview 140
  • 5.56 Symetis SA Company Overview 141
  • 5.57 Tel Aviv Sourasky Medical Center Company Overview 142
  • 5.58 TransCardiac Therapeutics, LLC Company Overview 143
  • 5.59 TTK Healthcare Ltd Company Overview 144
  • 5.60 University of Manitoba Company Overview 145
  • 5.61 University of Minnesota Company Overview 146
  • 5.62 University of South Carolina Company Overview 147
  • 5.63 Valcare Medical Company Overview 148
  • 5.64 Valtech Cardio Ltd Company Overview 152
  • 5.65 Vanderbilt University Company Overview 161
  • 5.66 Vascular Concepts Ltd Company Overview 162
  • 5.67 Viacor Inc Company Overview 163
  • 5.68 W. L. Gore & Associates Inc Company Overview 164

6 Cardiovascular Prosthetic Devices- Recent Developments 168

  • 6.1 May 24, 2018: Real-World Study Results Support Use of Abbott s AMPLATZER Amulet to Reduce Stroke in Patients Suffering from Atrial Fibrillation Without the Need for Lifetime Blood Thinners 168
  • 6.2 May 24, 2018: Medtronic Reports Fourth Quarter And Fiscal Year 2018 Financial Results 169
  • 6.3 May 24, 2018: CollPlant Announces First Quarter 2018 Financial Results 171
  • 6.4 May 21, 2018: Edwards Announces Key Events For EuroPCR 2018 173
  • 6.5 May 16, 2018: First patient treated in First-in-Man study of CoreMedic's ChordArt mitral valve repair system 174
  • 6.6 May 14, 2018: Ancora Heart Expands Enrollment of U.S. Early Feasibility Study for the AccuCinch System for Left Ventricular Repair 175
  • 6.7 May 08, 2018: Cardiac Dimensions Announces Appointment of Dr. Matthew Stark as Vice President of Clinical and Regulatory Affairs, Adds New Board Member 176
  • 6.8 May 08, 2018: Corindus Announces First Quarter 2018 Financial Results 177
  • 6.9 May 07, 2018: Medtronic Appoints Mike Weinstein As Senior Vice President Of Strategy 178
  • 6.10 May 02, 2018: Solvay's tough, biocompatible Radel PPSU selected for valve sizers in BioStable Science & Engineering's HAART 300 aortic annuloplasty kit 178
  • 6.11 May 02, 2018: CryoLife Announces First Quarter 2018 Financial Results 179
  • 6.12 Apr 30, 2018: Edwards Granted CE Mark For First Transcatheter Tricuspid Therapy 180
  • 6.13 Apr 30, 2018: Neochord DS1000 System Successfully Treats 20th Patient in Combination with Other Beating Heart Procedures 181
  • 6.14 Apr 26, 2018: Expanded Registry Data Shows Continued Positive Results For The Mitraclip Device 181
  • 6.15 Apr 25, 2018: Minimally Invasive Investigational Procedure Treats Mitral Regurgitation as an Alternative to Open Heart Surgery 182
  • 6.16 Apr 25, 2018: LeMaitre Q1 2018 Sales $26.0mm (+8%), EPS $0.19 (+17%) 183
  • 6.17 Apr 25, 2018: Xianjian Technology Receives the Most Attention from Institutional Investors 184
  • 6.18 Apr 24, 2018: Edwards Lifesciences Announces First Quarter 2018 Financial Results 184
  • 6.19 Apr 20, 2018: Cook Medical Appoints Christina Anne Vice President of Distribution Channel Management 186
  • 6.20 Apr 18, 2018: HeartStitch Announces CE Mark For CoAp Pro Mitral Valve Repair 186
  • 6.21 Apr 12, 2018: CollPlant Appoints Revital Mandil-Levin as Chief Business Development Officer 187
  • 6.22 Apr 05, 2018: Dr. Laura Mauri to Join Medtronic as Vice President, Global Clinical Research & Analytics 188
  • 6.23 Apr 03, 2018: FDA Approves GORE CARDIOFORM Septal Occluder for PFO Closure to Prevent Recurrent Ischemic Stroke 188
  • 6.24 Mar 29, 2018: Northwestern Memorial Hospital Surgeon First in Illinois to Repair Aortic Valve with Novel Ring 189
  • 6.25 Mar 23, 2018: 2017 fiscal year: B. Braun increases sales and earnings, with investments of one billion euros 190
  • 6.26 Mar 21, 2018: CollPlant Reports Fourth Quarter and Year End 2017 Financial Results and Provides Business Update 192
  • 6.27 Mar 19, 2018: Abbott's MitraClip Therapy Receives National Reimbursement in Japan to Treat Patients with Mitral Regurgitation 194
  • 6.28 Mar 14, 2018: Corindus Reports Fourth Quarter and Full Year 2017 Results 195
  • 6.29 Mar 12, 2018: BioVentrix Announces First Patient at Cardiovascular Institute of the South Successfully Treated in IDE Study of Revivent TC TransCatheter Ventricular Enhancement Treatment 196
  • 6.30 Mar 07, 2018: CryoLife Reports Fourth Quarter and Full Year 2017 Results 196
  • 6.31 Feb 28, 2018: LivaNova Announces Fourth Quarter and Full-Year 2017 Results 198
  • 6.32 Feb 22, 2018: Tricuspid Valve Repair Company 4Tech Appoints Tom Fleming as President and CEO, and Dr. Keith Dawkins as CMO 200
  • 6.33 Feb 22, 2018: Tricuspid Valve Repair Company 4Tech Appoints Tom Fleming as President and CEO, and Dr. Keith Dawkins as CMO 200
  • 6.34 Feb 21, 2018: LeMaitre Reports Net Income Of $4.3mm In Q4 2017 201
  • 6.35 Feb 13, 2018: Four start-ups chosen for the B. Braun Accelerator Program 202
  • 6.36 Feb 07, 2018: Caisson Interventional Expanding in Maple Grove 202
  • 6.37 Feb 06, 2018: BioVentrix Achieves 2018 NUB Reimbursement Status 1 in Germany for Revivent TC TransCatheter Ventricular Enhancement System 203
  • 6.38 Feb 01, 2018: Successful Clinical Application of China's First Transcatheter Mitral Valve Repair Device, MitralStitch 204
  • 6.39 Feb 01, 2018: Edwards Lifesciences Reports Fourth Quarter Results 204
  • 6.40 Jan 30, 2018: Alex Gu Named Senior Vice President and President of Medtronic's Greater China Region 206
  • 6.41 Jan 29, 2018: Mardil Medical Appoints Martin Madden to Board of Directors 207
  • 6.42 Jan 18, 2018: KEPHALIOS reports first patient implanted with Kalios, its breakthrough mitral valve repair device 207
  • 6.43 Jan 16, 2018: CollPlant Appoints David Tsur as Chairman of the Board 208
  • 6.44 Jan 08, 2018: Dongguan Kewei Attends 17th National Thoracic and Cardiovascular Surgery Congress 209
  • 6.45 Jan 08, 2018: LivaNova Announces Matthew J. Dodds as Senior Vice President, Corporate Development 209
  • 6.46 Jan 07, 2018: LifeTech Scientific and Ally Bridge Group Form China-Global Medtech Investment and Operating Partnership 210

7 Appendix 266

  • 7.1 Methodology 266
  • 7.2 About GlobalData 269
  • 7.3 Contact Us 269
  • 7.4 Disclaimer 269

List of Tables

1.1 List of Tables

  • Table 1: Cardiovascular Prosthetic Devices - Pipeline Products by Stage of Development 17
  • Table 2: Cardiovascular Prosthetic Devices - Pipeline Products by Segment 18
  • Table 3: Cardiovascular Prosthetic Devices - Pipeline Products by Territory 19
  • Table 4: Cardiovascular Prosthetic Devices - Pipeline Products by Regulatory Path 20
  • Table 5: Cardiovascular Prosthetic Devices - Pipeline Products by Estimated Approval Date 21
  • Table 6: Cardiovascular Prosthetic Devices - Ongoing Clinical Trials 22
  • Table 7: Cardiovascular Prosthetic Devices Companies - Pipeline Products by Stage of Development 23
  • Table 8: Cardiovascular Prosthetic Devices - Pipeline Products by Stage of Development 26
  • Table 9: 4Tech Cardio Ireland Ltd Pipeline Products & Ongoing Clinical Trials Overview 29
  • Table 10: TriCinch System - Product Status 29
  • Table 11: TriCinch System - Product Description 29
  • Table 12: 4Tech Cardio Ireland Ltd - Ongoing Clinical Trials Overview 30
  • Table 13: TriCinch System - Clinical Trial Evaluation of the Percutaneous 4Tech TriCinch Coil Tricuspid Valve Repair System 31
  • Table 14: TriCinch System - International Multisite Transcatheter Tricuspid Valve Therapies Registry 31
  • Table 15: Abbott Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview 32
  • Table 16: Transcatheter Tricuspid Valve Repair System - Product Status 32
  • Table 17: Transcatheter Tricuspid Valve Repair System - Product Description 32
  • Table 18: Abbott Vascular Inc - Ongoing Clinical Trials Overview 33
  • Table 19: Transcatheter Tricuspid Valve Repair System - Trial to Evaluate Treatment with Abbott Transcatheter Clip Repair System in Patients with Moderate or Greater Tricuspid Regurgitation: TRILUMINATE 34
  • Table 20: Admedus Ltd Pipeline Products & Ongoing Clinical Trials Overview 35
  • Table 21: 3D Curve - Product Status 35
  • Table 22: 3D Curve - Product Description 35
  • Table 23: Ample Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 36
  • Table 24: PS3 System - Product Status 36
  • Table 25: PS3 System - Product Description 36
  • Table 26: Ancora Heart Inc Pipeline Products & Ongoing Clinical Trials Overview 37
  • Table 27: AccuCinch Ventriculoplasty System - Product Status 37
  • Table 28: AccuCinch Ventriculoplasty System - Product Description 37
  • Table 29: Ancora Heart Inc - Ongoing Clinical Trials Overview 38
  • Table 30: AccuCinch Ventriculoplasty System - A Study of Percutaneous Treatment of Mitral Regurgitation Using the AccuCinch System 39
  • Table 31: Aporo Biomedical, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 40
  • Table 32: Patent Foramen Ovale Closure Device - Product Status 40
  • Table 33: Patent Foramen Ovale Closure Device - Product Description 40
  • Table 34: BioStable Science & Engineering, Inc. Pipeline Products & Ongoing Clinical Trials Overview 41
  • Table 35: HAART 200 Aortic Annuloplasty Device - Product Status 41
  • Table 36: HAART 200 Aortic Annuloplasty Device - Product Description 41
  • Table 37: BioVentrix Inc Pipeline Products & Ongoing Clinical Trials Overview 42
  • Table 38: Revivent-TC System - Product Status 42
  • Table 39: Revivent-TC System - Product Description 42
  • Table 40: BioVentrix Inc - Ongoing Clinical Trials Overview 43
  • Table 41: Revivent-TC System - Clinical Study of the BioVentrix Revivent TC for the Treatment of Ischemic Cardiomyopathy 44
  • Table 42: Revivent-TC System - Clinical Study of the BioVentrix Revivent TC System for Treatment of Left Ventricular Aneurysms 44
  • Table 43: CARAG AG Pipeline Products & Ongoing Clinical Trials Overview 45
  • Table 44: Solysafe Septal Occluder - Degradable Version - Product Status 45
  • Table 45: Solysafe Septal Occluder - Degradable Version - Product Description 45
  • Table 46: CARAG AG - Ongoing Clinical Trials Overview 46
  • Table 47: Solysafe Septal Occluder - Degradable Version - Prospective Single Center Pilot Clinical Study to Evaluate the Safety and Effectiveness of an Intracardiac Septal Closure Device with Biodegradable Framework in Patients with Clinically Significant Atrial Septum Defect (ASD) or Patent Foramen Ovale (PFO) 47
  • Table 48: Cardiac Dimensions Inc Pipeline Products & Ongoing Clinical Trials Overview 48
  • Table 49: CARILLON Mitral Contour System - Product Status 48
  • Table 50: CARILLON Mitral Contour System - Product Description 48
  • Table 51: Cardiac Dimensions Inc - Ongoing Clinical Trials Overview 49
  • Table 52: CARILLON Mitral Contour System - Assessment of the Carillon Mitral Contour System in Treating Functional Mitral Regurgitation Associated with Heart Failure 50
  • Table 53: CARILLON Mitral Contour System - The REDUCE FMR Trial: Safety and Efficacy of the CARILLON Mitral Contour System in Reducing Functional Mitral Regurgitation (FMR) Associated with Heart Failure 50
  • Table 54: Cardiosolutions Inc Pipeline Products & Ongoing Clinical Trials Overview 51
  • Table 55: Mitra-Spacer - Product Status 51
  • Table 56: Mitra-Spacer - Product Description 51
  • Table 57: Celyad SA Pipeline Products & Ongoing Clinical Trials Overview 52
  • Table 58: Cardiao3 Closure Device - Product Status 52
  • Table 59: Cardiao3 Closure Device - Product Description 52
  • Table 60: Heart Access Sheath - Mitral Valve Repair - Product Status 53
  • Table 61: Heart Access Sheath - Mitral Valve Repair - Product Description 53
  • Table 62: Mitral Valve Neo-chordae - Product Status 53
  • Table 63: Mitral Valve Neo-chordae - Product Description 54
  • Table 64: Children's Hospital Boston Pipeline Products & Ongoing Clinical Trials Overview 55
  • Table 65: Endovascular Prosthesis - Product Status 55
  • Table 66: Endovascular Prosthesis - Product Description 55
  • Table 67: Mitral Valve Repair Clip - Product Status 56
  • Table 68: Mitral Valve Repair Clip - Product Description 56
  • Table 69: Tricuspid Valve Repair Device - Product Status 56
  • Table 70: Tricuspid Valve Repair Device - Product Description 56
  • Table 71: Cierra, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 57
  • Table 72: PFx Closure System - Product Status 57
  • Table 73: PFx Closure System - Product Description 57
  • Table 74: CollPlant Ltd Pipeline Products & Ongoing Clinical Trials Overview 58
  • Table 75: VergenixHVR - Product Status 58
  • Table 76: VergenixHVR - Product Description 58
  • Table 77: coramaze technologies GmbH Pipeline Products & Ongoing Clinical Trials Overview 59
  • Table 78: Mitramaze Valve Repair System - Product Status 59
  • Table 79: Mitramaze Valve Repair System - Product Description 59
  • Table 80: CoreMedic AG Pipeline Products & Ongoing Clinical Trials Overview 60
  • Table 81: ChordArt - Product Status 60
  • Table 82: ChordArt - Product Description 60
  • Table 83: CoreMedic AG - Ongoing Clinical Trials Overview 61
  • Table 84: ChordArt - First-in-man Chagall Study on Safety and Efficacy of ChordArt Mitral Valve Repair System 62
  • Table 85: Coroneo Inc. Pipeline Products & Ongoing Clinical Trials Overview 63
  • Table 86: Extra-Aortic Annuloplasty Ring - Product Status 63
  • Table 87: Extra-Aortic Annuloplasty Ring - Product Description 63
  • Table 88: CUBE SRL Pipeline Products & Ongoing Clinical Trials Overview 64
  • Table 89: Mitral-FERCube Ring - Product Status 64
  • Table 90: Mitral-FERCube Ring - Product Description 64
  • Table 91: Daidalos Solutions BV Pipeline Products & Ongoing Clinical Trials Overview 65
  • Table 92: Sutureless Mitral Valve Repair Ring - Product Status 65
  • Table 93: Sutureless Mitral Valve Repair Ring - Product Description 65
  • Table 94: Sutureless Tricuspid Valve Repair Ring - Product Status 66
  • Table 95: Sutureless Tricuspid Valve Repair Ring - Product Description 66
  • Table 96: Dextera Surgical Inc Pipeline Products & Ongoing Clinical Trials Overview 67
  • Table 97: PFO Closure Device - Product Status 67
  • Table 98: PFO Closure Device - Product Description 67
  • Table 99: Edwards Lifesciences Corp Pipeline Products & Ongoing Clinical Trials Overview 68
  • Table 100: Alterra Adaptive Prestent - Product Status 68

List of Figures

1.2 List of Figures

  • Figure 1: Cardiovascular Prosthetic Devices - Pipeline Products by Stage of Development 17
  • Figure 2: Cardiovascular Prosthetic Devices - Pipeline Products by Segment 18
  • Figure 3: Cardiovascular Prosthetic Devices - Pipeline Products by Territory 19
  • Figure 4: Cardiovascular Prosthetic Devices - Pipeline Products by Regulatory Path 20
  • Figure 5: Cardiovascular Prosthetic Devices - Pipeline Products by Estimated Approval Date 21
  • Figure 6: Cardiovascular Prosthetic Devices - Ongoing Clinical Trials 22
Back to Top